RET and lung carcinoma: Given that patients with c-RET fusions do not harbor mutations or fusions in EGFR, KRAS or ALK oncogenes, it is likely that c-RET fusion genes represent lung adenocarcinoma drivers and will lead to the definition of a new subclass of lung cancer [5].